Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Walmart shooter left 'death note,' bought gun day of killing
See how to make money instead of spending it on Black Friday with this offer (Ad)
US stocks wobble to a mixed close, indexes keep weekly gains
Arrival, Coupa Software rise; Apple, Activision fall
See how to make money instead of spending it on Black Friday with this offer (Ad)
New this week: Lizzo, 'Criminal Minds' and 'The Woman King'
Police: Walmart shooter bought gun just hours before killing
THE BEST BLACK FRIDAY DEAL YET (Ad)
Musk says granting 'amnesty' to suspended Twitter accounts
Musk plans to relaunch Twitter premium service, again
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Walmart shooter left 'death note,' bought gun day of killing
See how to make money instead of spending it on Black Friday with this offer (Ad)
US stocks wobble to a mixed close, indexes keep weekly gains
Arrival, Coupa Software rise; Apple, Activision fall
See how to make money instead of spending it on Black Friday with this offer (Ad)
New this week: Lizzo, 'Criminal Minds' and 'The Woman King'
Police: Walmart shooter bought gun just hours before killing
THE BEST BLACK FRIDAY DEAL YET (Ad)
Musk says granting 'amnesty' to suspended Twitter accounts
Musk plans to relaunch Twitter premium service, again
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Walmart shooter left 'death note,' bought gun day of killing
See how to make money instead of spending it on Black Friday with this offer (Ad)
US stocks wobble to a mixed close, indexes keep weekly gains
Arrival, Coupa Software rise; Apple, Activision fall
See how to make money instead of spending it on Black Friday with this offer (Ad)
New this week: Lizzo, 'Criminal Minds' and 'The Woman King'
Police: Walmart shooter bought gun just hours before killing
THE BEST BLACK FRIDAY DEAL YET (Ad)
Musk says granting 'amnesty' to suspended Twitter accounts
Musk plans to relaunch Twitter premium service, again
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Walmart shooter left 'death note,' bought gun day of killing
See how to make money instead of spending it on Black Friday with this offer (Ad)
US stocks wobble to a mixed close, indexes keep weekly gains
Arrival, Coupa Software rise; Apple, Activision fall
See how to make money instead of spending it on Black Friday with this offer (Ad)
New this week: Lizzo, 'Criminal Minds' and 'The Woman King'
Police: Walmart shooter bought gun just hours before killing
THE BEST BLACK FRIDAY DEAL YET (Ad)
Musk says granting 'amnesty' to suspended Twitter accounts
Musk plans to relaunch Twitter premium service, again
NASDAQ:CYTR

CytRx - CYTR Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
N/A
50-Day Range
$0.08
$0.13
52-Week Range
N/A
Volume
4,000 shs
Average Volume
99,706 shs
Market Capitalization
$4.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CYTR stock logo

About CytRx (NASDAQ:CYTR) Stock

CytRx Corporation, a biopharmaceutical research and development company, focuses on oncology and rare diseases. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company's lead candidates include linker activated drug release (LADR) -7, LADR-8, LADR-9, and LADR-10; and Aldoxorubicin, a conjugate of prescribed cytotoxin agent doxorubicin that binds to circulating albumin in the bloodstream and to concentrate the drug at the site of the tumor. It also provides ACDx, an albumin companion diagnostic product to identify patients with cancer who are most likely to benefit from treatment with these drug candidates. CytRx Corporation was incorporated in 1985 and is headquartered in Los Angeles, California.

Receive CYTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CytRx and its competitors with MarketBeat's FREE daily newsletter.

CYTR Stock News Headlines

See More Headlines

Receive CYTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CytRx and its competitors with MarketBeat's FREE daily newsletter.

CYTR Company Calendar

Today
11/26/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CYTR
Employees
3
Year Founded
N/A

Profitability

Net Income
$-13,180,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.02 per share

Miscellaneous

Free Float
39,912,000
Market Cap
$4.14 million
Optionable
Not Optionable
Beta
1.82

Key Executives

  • Mr. John Y. Caloz (Age 70)
    CFO, Treasurer & Sr. VP
    Comp: $500k
  • Dr. Stephen Snowdy Ph.D. (Age 52)
    Chief Exec. Officer
  • Molly Carey Poarch
    Global & U.S. Head of Corp. Communications
  • Ms. Molly Painter (Age 46)
    Pres of USA and Head of Launch & Commercial Operations
  • Terri Stevens
    Chief Bus. Officer
  • Ms. Cristina Newman
    Corp. Sec.
  • Dr. Felix Kratz Ph.D. (Age 59)
    Sr. VP, Drug Devel.













CYTR Stock - Frequently Asked Questions

What is CytRx's stock symbol?

CytRx trades on the NASDAQ under the ticker symbol "CYTR."

How much money does CytRx make?

CytRx (NASDAQ:CYTR) has a market capitalization of $0.00.

How can I contact CytRx?

CytRx's mailing address is 11726 San Vicente Blvd Ste 650, Los Angeles, California 90049-5079. The official website for the company is www.cytrx.com. The company can be reached via phone at (310) 826-5648, via email at info@cytrx.com, or via fax at 310-826-6139.

This page (NASDAQ:CYTR) was last updated on 11/26/2022 by MarketBeat.com Staff